Perspectives on the development of imatinib and the future of cancer research

被引：76

作者：

Druker, Brian J. ^{[1
,2
,3
]}

机构：

[1] Howard Hughes Med Inst, Portland, OR USA

[2] Leukemia Res, Portland, OR USA

[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

来源：

NATURE MEDICINE | 2009年 / 15卷 / 10期

关键词：

CLINICAL-TRIALS; LUNG-CANCER; MUTATIONS; MESYLATE; TUMORS;

D O I：

10.1038/nm1009-1149

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1149 / 1152

页数：4

共 23 条

[11] Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers. [J].

Fong, Peter C. ;

Boss, David S. ;

Yap, Timothy A. ;

Tutt, Andrew ;

Wu, Peijun ;

Mergui-Roelvink, Marja ;

Mortimer, Peter ;

Swaisland, Helen ;

Lau, Alan ;

O'Connor, Mark J. ;

Ashworth, Alan ;

Carmichael, James ;

Kaye, Stan B. ;

Schellens, Jan H. M. ;

de Bono, Johann S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (02) :123-134

[12] Major response to imatinib mesylate in KIT-mutated melanoma [J].

Hodi, F. Stephen ;

Friedlander, Philip ;

Corless, Christopher L. ;

Heinrich, Michael C. ;

Mac Rae, Suzanne ;

Kruse, Andrea ;

Jagannathan, Jyothi ;

Van den Abbeele, Annick D. ;

Velazquez, Elsa F. ;

Demetri, George D. ;

Fisher, David E. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) :2046-2051

[13] Enhancing the Efficacy of Hormonal Agents with Selected Targeted Agents [J].

Johnston, Stephen R. D. .

CLINICAL BREAST CANCER, 2009, 9 :S28-S36

[14] Core signaling pathways in human pancreatic cancers revealed by global genomic analyses [J].

Jones, Sian ;

Zhang, Xiaosong ;

Parsons, D. Williams ;

Lin, Jimmy Cheng-Ho ;

Leary, Rebecca J. ;

Angenendt, Philipp ;

Mankoo, Parminder ;

Carter, Hannah ;

Kamiyama, Hirohiko ;

Jimeno, Antonio ;

Hong, Seung-Mo ;

Fu, Baojin ;

Lin, Ming-Tseh ;

Calhoun, Eric S. ;

Kamiyama, Mihoko ;

Walter, Kimberly ;

Nikolskaya, Tatiana ;

Nikolsky, Yuri ;

Hartigan, James ;

Smith, Douglas R. ;

Hidalgo, Manuel ;

Leach, Steven D. ;

Klein, Alison P. ;

Jaffee, Elizabeth M. ;

Goggins, Michael ;

Maitra, Anirban ;

Iacobuzio-Donahue, Christine ;

Eshleman, James R. ;

Kern, Scott E. ;

Hruban, Ralph H. ;

Karchin, Rachel ;

Papadopoulos, Nickolas ;

Parmigiani, Giovanni ;

Vogelstein, Bert ;

Velculescu, Victor E. ;

Kinzler, Kenneth W. .

SCIENCE, 2008, 321 (5897) :1801-1806

[15]

Kwak EL, 2009, J CLIN ONCOL, V27

[16] KHOURY,GEORGE - (1943-1987) - OBITUARY [J].

LIVINGSTON, DM .

CELL, 1987, 49 (05) :577-577

[17] Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].

Lynch, TJ ;

Bell, DW ;

Sordella, R ;

Gurubhagavatula, S ;

Okimoto, RA ;

Brannigan, BW ;

Harris, PL ;

Haserlat, SM ;

Supko, JG ;

Haluska, FG ;

Louis, DN ;

Christiani, DC ;

Settleman, J ;

Haber, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139

[18]

O'Brien SG, 2008, BLOOD, V112, P76

[19]

O'Shaughnessy J, 2009, J CLIN ONCOL, V27

[20] EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy [J].

Paez, JG ;

Jänne, PA ;

Lee, JC ;

Tracy, S ;

Greulich, H ;

Gabriel, S ;

Herman, P ;

Kaye, FJ ;

Lindeman, N ;

Boggon, TJ ;

Naoki, K ;

Sasaki, H ;

Fujii, Y ;

Eck, MJ ;

Sellers, WR ;

Johnson, BE ;

Meyerson, M .

SCIENCE, 2004, 304 (5676) :1497-1500

← 1 2 3 →